Literature DB >> 6302738

The effect of synthetic leukotrienes on tracheal microvascular permeability.

D F Woodward, B M Weichman, C A Gill, M A Wasserman.   

Abstract

The effect of synthetic leukotrienes (LT) C4, D4 and E4 on the permeability of the airway microvasculature to plasma albumin was quantitatively evaluated using an in situ guinea pig tracheal model. Vascular permeability was measured as extravascular albumin content by employing 125I-bovine serum albumin and, in order to correct for blood volume, 51Cr-erythrocytes were used. Intratracheal injection of synthetic LTC4, LTD4 and LTE4 (0.1-1000 ng) produced dose-dependent increases in tracheal extravascular albumin content. The leukotrienes were approximately 100-1000 fold more potent than histamine, although histamine did produce a greater maximal increase in extravascular albumin than the leukotrienes. Methacholine did not increase extravascular albumin content. The microvascular permeability effect of LTD4 was antagonized by FPL 55712 but not by mepyramine; conversely, the effect of histamine was antagonized by mepyramine and not by FPL 55712. Additionally, indomethacin did not alter the LTD4-induced increases in tracheal vascular permeability. These results suggest that the effect of LTD4 on tracheal microvascular permeability is directly mediated and is not the indirect result of cholinergic stimulation, histamine release or de novo synthesis of cyclooxygenase products.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302738     DOI: 10.1016/0090-6980(83)90142-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  13 in total

1.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

2.  Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

Authors:  A P Sampson; R U Thomas; J F Costello; P J Piper
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

3.  Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.

Authors:  J T Zakrzewski; N C Barnes; P J Piper; J F Costello
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

4.  The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction.

Authors:  I Joris; G Majno; E J Corey; R A Lewis
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

5.  Unopposed interleukin-1 is necessary for increased plasma cytokine and eicosanoid levels to develop in severe sepsis.

Authors:  G J Slotman; J V Quinn; P C Wry; C E Brathwaite; B M Friedman
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

6.  The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.

Authors:  J R Boot; A Bond; R Gooderham; A O'Brien; M Parsons; K H Thomas
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor.

Authors:  H Arakawa; J Lötvall; I Kawikova; C G Löfdahl; B E Skoogh
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 8.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

Review 9.  Leukotriene and thromboxane antagonists.

Authors:  T Obata; N Yamashita; T Nakagawa
Journal:  Clin Rev Allergy       Date:  1994

10.  Persistent increase in plasma and urinary leukotrienes after acute asthma.

Authors:  A P Sampson; D P Castling; C P Green; J F Price
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.